Keywords: کنگوات های آنتی بادی; Head and neck squamous cell carcinoma; Functional genomic mRNA profiling; Antibody-drug conjugates; Immunohistochemistry;
مقالات ISI کنگوات های آنتی بادی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کنگوات های آنتی بادی; 2D-LC; Aggregate; Antibody-drug conjugates; Free payloads; RPLC; Size exclusion chromatography;
Keywords: کنگوات های آنتی بادی; Antibody engineering; Antibody fragments; Bacterial production; Cetuximab Fab; Humanization; Antibody-drug conjugates;
Keywords: کنگوات های آنتی بادی; Antibody-drug conjugates; Pyrrolobenzodiazepines; Macrocycles;
Keywords: کنگوات های آنتی بادی; Acute myeloid leukemia; Acute lymphoblastic leukemia; Immunotherapy; Checkpoint inhibitors; BiTEs; Antibody-drug conjugates; Inotuzumab; Blinatumomab; CART cells;
Keywords: کنگوات های آنتی بادی; 2-DG; 2-deoxyglucose; 2-HG; 2-hydroxyglutarate; 5mC; 5-methlycystosine; ACACA; acetyl-CoA carboxylase; AML; acute myeloid leukemia; AMPK; adenosine monophosphate-activated protein kinase; ATP; adenosine triphosphate; ALDH; aldehyde dehydrogenase; ADCs; an
Keywords: کنگوات های آنتی بادی; Cancer; Target therapy; Prodrug; MDR; Multidrug resistance; ROS; Reactive oxygen species; GSH; Glutathione; ADCs; Antibody-drug conjugates; ADEPT; Antibody-directed enzyme prodrug therapy; GDEPT; Gene-directed enzyme prodrug therapy; HIF; Hypoxia-inducibl
Keywords: کنگوات های آنتی بادی; mAb; monoclonal antibody; HAMA; human anti-mouse antibody; HACA; human anti-chimeric antibody; HAHA; human anti-humanized antibody; ADC; antibody-drug conjugates; Biologics; Monoclonal antibodies; Fusion proteins; Immunotherapy; Clinical immunology;
Keywords: کنگوات های آنتی بادی; 2D-LC; two-dimensional liquid chromatography; AA; amino acid; AC; affinity chromatography; ADC; antibody-drug conjugates; ADCC; antibody-dependent cellular cytotoxicity; AF4; asymmetric flow field fractionation; APTS; 1-aminopyrene-3,6,8-trisulfonate; Asn
Keywords: کنگوات های آنتی بادی; Cysteine-engineered antibodies; Site-specific conjugation; Antibody-drug conjugates; In vivo efficacy; Tubulysin; Fc-gamma receptors;
In situ quantitative bioanalysis of monomethyl auristatin E-conjugated antibody-drug conjugates by flow cytometry
Keywords: کنگوات های آنتی بادی; Antibody-drug conjugates; Ligand-binding assay; Flow cytometry; In situ bioanalysis; Ofatumumab;
Site-specific and hydrophilic ADCs through disulfide-bridged linker and branched PEG
Keywords: کنگوات های آنتی بادی; ADC; antibody-drug conjugates; MMAE; monomethyl auristatin E; DAR; dhrug-to-antibody ratio; DTT; ditiothreitol; TCEP; (tris(2-carboxyethyl)phosphine; T-DM1; Trastuzumab emtansine; DM1; Mertansine; SMCC; Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-ca
Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy
Keywords: کنگوات های آنتی بادی; Shiga toxin; Shiga toxin subunit B; Intracellular delivery; Receptor-mediated endocytosis; Toxin-drug conjugates; Antibody-drug conjugates; Biotechnological production; Cancer targeting;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: کنگوات های آنتی بادی; Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
An optimised synthesis of SG3376, a non-cleavable antibody-drug conjugate pyrrolobenzodiazepine drug-linker
Keywords: کنگوات های آنتی بادی; Antibody-drug conjugates; Pyrrolobenzodiazepine; BOC deprotection; Talirine; Tesirine;
A generic approach for simultaneous measurements of total antibody and cleavable antibody-conjugated drug by LC/MS/MS
Keywords: کنگوات های آنتی بادی; Antibody-drug conjugates; Antibody quantification; Drug Antibody Ratio; Antibody-conjugated drug; MMAE;
Novel Immunotherapy Approaches in AML: Focus on Monoclonal Antibodies
Keywords: کنگوات های آنتی بادی; Acute myeloid leukemia; Target antigens; Bispecific antibodies; Antibody-drug conjugates; Radioimmunotherapy;
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates
Keywords: کنگوات های آنتی بادی; Antibody-drug conjugates; Drug design; In vivo efficacy; Mouse xenograft; Lysosomal release; Pharmacokinetics;
A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo
Keywords: کنگوات های آنتی بادی; Antibodies; Protein engineering; Vascular targeting; Antibody-drug conjugates; Anthracyclines;
Protocols for the analytical characterization of therapeutic monoclonal antibodies. I - Non-denaturing chromatographic techniques
Keywords: کنگوات های آنتی بادی; Size exclusion chromatography; Ion exchange chromatography; Hydrophobic interaction chromatography; Therapeutic monoclonal antibodies; Antibody-drug conjugates; Protocol;
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson's disease - Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
Keywords: کنگوات های آنتی بادی; Poly(2-oxazoline) or POZ; Poly(2-methyloxazoline) or PMOZ; Poly(2-ethyloxazoline) or PEOZ; Parkinson's disease; SER-214; Pharmacokinetics; Toxicology; Distribution; Immunogenicity; Preclinical; Clinical; Antibody-drug conjugates; Whole body autoradiogra
A high-throughput hydrophilic interaction liquid chromatography coupled with a charged aerosol detector method to assess trisulfides in IgG1 monoclonal antibodies using tris(2-carboxyethyl)phosphine reaction products: Tris(2-carboxyethyl)phosphine-oxide a
Keywords: کنگوات های آنتی بادی; Trisulfides; Hydrophilic interaction chromatography; Charged aerosol detector; Tris(2-carboxyethyl)phosphine (TCEP); Tris(2-carboxyethyl)phosphine-oxide (TCEP[O]); Tris(2-carboxyethyl)phosphine-sulfide (TCEP[S]); Antibody-drug conjugates; Monoclonal antib
An FDA oncology analysis of antibody-drug conjugates
Keywords: کنگوات های آنتی بادی; AD; acceptable dose; ADC; antibody-drug conjugate; ADCC; antibody-dependent cellular cytotoxicity; FIH; first-in-human; HNSTD; highest non-severely toxic dose; ICH; International Conference on Harmonization; LC/MS; liquid chromatography/mass spectrometry;
Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugates
Keywords: کنگوات های آنتی بادی; ADCs; antibody-drug conjugates; DAR; drug-to-antibody ratio; SALCL; systemic anaplastic large cell lymphoma; LC/MS/MS; liquid chromatography tandem mass spectrometry; DIC; N,Nâ²-diisopropylcarbodiimide; DCC; dicyclohexylcarbodiimide; DCM; dichloromethane
Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability
Keywords: کنگوات های آنتی بادی; Breast cancer; HER2; Ado-trastuzumab emtansine; T-DM1; Toxicology; Antibody-drug conjugates;